Effect of pyruvate, lactate and insulin on ATP supply and demand in unpaced perfused rat heart. 2009

Bernard Korzeniewski, and Véronique Deschodt-Arsac, and Guillaume Calmettes, and Gilles Gouspillou, and Jean-Michel Franconi, and Philippe Diolez
Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland. benio@mol.uj.edu.pl

Mitochondrial respiration/oxidative phosphorylation is the main source of energy, in the form of ATP, in the heart under physiological conditions. Different respiratory substrates were used in various experiments during heart perfusion: glucose, pyruvate, lactate, glucose+pyruvate, glucose+lactate, glucose+insulin etc. Also under physiological conditions, the concentration of respiratory substrates/hormones in blood can vary significantly. In the present study, we tested the effect of pyruvate, lactate and insulin (all in the presence of glucose) and glucose (in the presence of pyruvate) on the ATP-producing and -consuming blocks in perfused rat heart, in a system where HR (heart rate) was allowed to vary (no pacing). Changes in RPP (rate-pressure product) and PCr (phosphocreatine) concentration were measured. PAA (Proportional Activation Approach) was used to visualize and quantitatively analyse the data. It was demonstrated that addition of glucose (in the presence of pyruvate) exerted essentially no effect on the system. Insulin (in the presence of glucose) activated only the ATP producer. The most interesting finding is that, in our system, pyruvate and lactate (added in the presence or instead of glucose) activated ATP producer, but significantly inhibited ATP consumer (their effect was quantitatively identical).

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010725 Phosphocreatine An endogenous substance found mainly in skeletal muscle of vertebrates. It has been tried in the treatment of cardiac disorders and has been added to cardioplegic solutions. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1996) Creatine Phosphate,Neoton,Phosphocreatine, Disodium Salt,Phosphorylcreatine,Disodium Salt Phosphocreatine,Phosphate, Creatine
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013549 Sweetening Agents Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) Artificial Sweeteners,Sugar Substitutes,Sweeteners,Agent, Sweetening,Agents, Sweetening,Artificial Sweetener,Substitute, Sugar,Substitutes, Sugar,Sugar Substitute,Sweetener,Sweetener, Artificial,Sweeteners, Artificial,Sweetening Agent

Related Publications

Bernard Korzeniewski, and Véronique Deschodt-Arsac, and Guillaume Calmettes, and Gilles Gouspillou, and Jean-Michel Franconi, and Philippe Diolez
March 1996, The American journal of physiology,
Bernard Korzeniewski, and Véronique Deschodt-Arsac, and Guillaume Calmettes, and Gilles Gouspillou, and Jean-Michel Franconi, and Philippe Diolez
December 1969, The American journal of physiology,
Bernard Korzeniewski, and Véronique Deschodt-Arsac, and Guillaume Calmettes, and Gilles Gouspillou, and Jean-Michel Franconi, and Philippe Diolez
April 1972, The Biochemical journal,
Bernard Korzeniewski, and Véronique Deschodt-Arsac, and Guillaume Calmettes, and Gilles Gouspillou, and Jean-Michel Franconi, and Philippe Diolez
July 1973, European journal of biochemistry,
Bernard Korzeniewski, and Véronique Deschodt-Arsac, and Guillaume Calmettes, and Gilles Gouspillou, and Jean-Michel Franconi, and Philippe Diolez
November 1963, The American journal of physiology,
Bernard Korzeniewski, and Véronique Deschodt-Arsac, and Guillaume Calmettes, and Gilles Gouspillou, and Jean-Michel Franconi, and Philippe Diolez
April 1979, Archives of biochemistry and biophysics,
Bernard Korzeniewski, and Véronique Deschodt-Arsac, and Guillaume Calmettes, and Gilles Gouspillou, and Jean-Michel Franconi, and Philippe Diolez
September 1982, The Biochemical journal,
Bernard Korzeniewski, and Véronique Deschodt-Arsac, and Guillaume Calmettes, and Gilles Gouspillou, and Jean-Michel Franconi, and Philippe Diolez
September 1982, The Biochemical journal,
Bernard Korzeniewski, and Véronique Deschodt-Arsac, and Guillaume Calmettes, and Gilles Gouspillou, and Jean-Michel Franconi, and Philippe Diolez
July 1973, European journal of biochemistry,
Bernard Korzeniewski, and Véronique Deschodt-Arsac, and Guillaume Calmettes, and Gilles Gouspillou, and Jean-Michel Franconi, and Philippe Diolez
April 1985, The Biochemical journal,
Copied contents to your clipboard!